Abstract:In the mouse embryo, the transition from the preimplantation to the postimplantation epiblast is governed by changes in the gene regulatory network (GRN) that lead to transcriptional, epigenetic, and functional changes. This transition can be faithfully recapitulated in vitro by the differentiation of mouse embryonic stem cells (mESCs) to epiblast-like cells (EpiLCs), that reside in naïve and formative states of pluripotency, respectively. However, the GRN that drives this conversion is not fully elucidated. Here we demonstrate that the transcription factor OCT6 is a key driver of this process. Firstly, we show that Oct6 is not expressed in mESCs but is rapidly induced as cells exit the naïve pluripotent state. By deleting Oct6 in mESCs, we find that knockout cells fail to acquire the typical morphological changes associated with the formative state when induced to differentiate. Additionally, the key naïve pluripotency TFs Nanog, Klf2, Nr5a2, Prdm14, and Esrrb were expressed at higher levels than in wild-type cells, indicating an incomplete dismantling of the naïve pluripotency GRN. Conversely, premature expression of Oct 6 in naïve cells triggered a rapid morphological transformation mirroring differentiation, that was accompanied by the upregulation of the endogenous Oct6 as well as the formative genes Sox3 , Zic2/3, Foxp1, Dnmt3A and FGF5. Strikingly, we found that OCT6 represses Nanog in a bistable manner and that this regulation is at the transcriptional level. Moreover, our findings also reveal that Oct6 is repressed by NANOG. Collectively, our results establish OCT6 as a key TF in the dissolution of the naïve pluripotent state and support a model where Oct6 and Nanog form a double negative feedback loop which could act as an important toggle mediating the transition to the formative state.

ZIC2 and ZIC3 promote SWI/SNF recruitment to safeguard progression towards human primed pluripotency

Zic3 is required for maintenance of pluripotency in embryonic stem cells

ZFP281 controls transcriptional and epigenetic changes promoting mouse pluripotent state transitions via DNMT3 and TET1

Zic2 is an Enhancer-Binding Factor Required for Embryonic Stem Cell Specification

Chromatin Landscape Dynamics During Reprogramming Towards Human Naïve and Primed Pluripotency Reveals the Divergent Function of PRDM1 Isoforms.

ID proteins promote the survival and primed-to-naive transition of human embryonic stem cells through TCF3-mediated transcription

Epigenomic Analysis of Gastrulation Identifies a Unique Chromatin State for Primed Pluripotency

Decoding molecular markers and transcriptional circuitry of naive and primed states of human pluripotency

ZFP281 Coordinates DNMT3 and TET1 for Transcriptional and Epigenetic Control in Pluripotent State Transitions

The regulatory architecture of the primed pluripotent cell state

Dynamic Chromatin States in Human ES Cells Reveal Potential Regulatory Sequences and Genes Involved in Pluripotency.

Epigenetic priming of embryonic enhancer elements coordinates developmental gene networks

The SIN3A/HDAC Corepressor Complex Functionally Cooperates with NANOG to Promote Pluripotency.

An Intermediate Pluripotent State Controlled by MicroRNAs is Required for the Naive-to-Primed Stem Cell Transition.

Combinatorial Smad2/3 Activities Downstream of Nodal Signaling Maintain Embryonic/Extra-Embryonic Cell Identities during Lineage Priming

Relaxed 3D Genome Conformation Facilitates the Pluripotent to Totipotent State Transition in Embryonic Stem Cells

Multifaceted SOX2-chromatin interaction underpins pluripotency progression in early embryos

Relaxed 3D genome conformation facilitates the pluripotent to totipotent-like state transition in embryonic stem cells

Transcriptional Repression by the BRG1-SWI/SNF Complex Affects the Pluripotency of Human Embryonic Stem Cells

Super-enhancers Conserved Within Placental Mammals Maintain Stem Cell Pluripotency

The transcription factor OCT6 promotes the dissolution of the naïve pluripotent state by repressing Nanog and activating a formative state gene regulatory network